Trials / Unknown
UnknownNCT03648801
A Post-marketing Surveillance to Assess Safety and Efficacy of Telostop Plus Tab.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Post-marketing surveillance of Telostop Plus Tab.
Detailed description
This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.
Conditions
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2024-05-01
- Completion
- 2024-08-01
- First posted
- 2018-08-27
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT03648801. Inclusion in this directory is not an endorsement.